Applications are invited to join a research programme focussing on development of novel therapeutics for the treatment of brain cancers, funded by The Brain Cancer Charity. You will be based in the Northern Institute for Cancer Research (NICR) and Institute of Cellular Medicine (ICM), under the supervision of Dr Jason Gill (NICR) and Dr Jonathan Harburn (ICM).

You will focus specifically on chemical synthesis and pharmacological characterisation of a novel tumour-selective therapy as a post-operative approach for the treatment of aggressive brain cancers. You will possess a Masters level qualification and PhD in cancer pharmacology, medicinal chemistry or drug development for appointment at Associate level, and a keen interest to develop your research skills in these areas. You will have the ability to work independently and play a leading role in the research project as well as possessing strong communication skills.

This position is tenable from 1st October 2017 for a period of 12 months.

Further information can be found here: Northern Institute for Cancer Research Faculty of Medical Sciences

Please click here for details

Please be advised that due to a new minimum salary threshold of £30,000 per annum imposed by the UKVI, this post may not qualify for University sponsorship under Tier 2 of the points based system.

The Institute holds a silver Athena SWAN award in addition to the University’s silver award in recognition of our good employment practices for the advancement of gender equality. The University also holds the HR Excellence in Research award for our work to support the career development of our researchers, and is a member of the Euraxess initiative supporting researchers in Europe.